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Abstract
Background:  The antibody microarray technique is a newly emerging proteomics tool for
differential protein expression analyses that uses fluorescent dyes Cy 3 and Cy 5. Environmental
factors, such as light exposure, can affect the signal intensity of fluorescent dyes on microarray
slides thus, it is logical to scan microarray slides immediately after the final wash and drying
processes. However, no research data are available concerning time-dependent changes of
fluorescent signals on antibody microarray slides to this date. In the present study, microarray
slides were preserved at -20°C after regular microarray experiments and were rescanned at day
10, 20 and 30 to evaluate change in signal intensity.
Results: Fluorescent intensities of microarray spots were detected using a confocal laser scanner
after the experiment at day 0, and re-examined at day 10, 20 and 30, respectively. Fluorescent
intensities of rescanned microarray spots did not show significant changes when compared with
those scanned immediately after standard microarray experiments.
Conclusion: Microarray slides can be preserved and rescanned multiple times using a confocal
laser scanner over a period of days or weeks.
Background
Antibody microarray analyses of protein expression levels
represent a new trend of cutting-edge proteomics research
[1-6], and have been increasingly utilized in studies of
normal and pathological conditions [7-22]. The tech-
nique has several distinct advantages. First, compared to
the cDNA microarray analysis, antibody microarrays
detect differential gene expression at the protein level.
Although cDNA microarray analyses have generated a
large database concerning gene expression patterns, most
of these studies have focused on gene expression at the
mRNA level only, with the assumption that the relative
mRNA levels represent the relative levels of proteins. Since
there is often a poor correlation between mRNA levels and
protein levels [23-28], this assumption may not be true
for many of the genes. Second, the antibody microarray
technique is more sensitive compared to gel electro-
phoreses. With microarray technology, protein levels can
be detected in the low pg/ml range. This allows the meas-
urement of the expression of both small and large molec-
ular weight proteins simultaneously, regardless of their
isoelectric points. In addition, some protein extraction
buffers used for antibody microarray experiments contain
non-denaturing detergents in order to keep the proteins in
their native state. While gel electrophoreses usually sepa-
rate denatured proteins for expression analyses, antibody
microarrays can measure relative abundance of naïve
undenatured proteins.
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The vast majority of antibody microarray experiments
conducted so far used the fluorescent dyes Cy3 and Cy5
for protein labelling. In general, fluorescent dyes are sen-
sitive to light exposure as well as other environmental fac-
tors such as water, high temperature, alkali, and alcohol.
Recent evidence indicates that even ozone levels in the
laboratory atmosphere could affect fluorescent dyes on
microarrays [29]. In order to avoid or to minimize the
effects of these risk factors, it is appropriate to scan micro-
array slides instantly upon finishing the final wash and
drying processes without unnecessary delays. However,
no data are currently available concerning time-depend-
ent changes of fluorescent signals on antibody microarray
slides. Furthermore, the published research on repeated
scans of antibody or protein microarrays is scant.
Although repeated scans of cDNA microarrays have been
conducted [30-35], it is not known whether amine-cou-
pled fluorescent dyes on antibody/protein microarrays
behave in the same way as those nucleotide-coupled fluo-
rescent dyes on cDNA microarrays. In addition, previous
studies conducted multiple scans of cDNA microarrays
sequentially, usually within minutes. Therefore, it is also
unknown whether prolonged intervals between scans in
the range of days or weeks could modify the signal inten-
sity of fluorescent dyes on antibody or protein microar-
rays. Furthermore, previous rescan studies were
conducted using different laser power levels or photomul-
tiplier tube (PMT) gains rather than using a consistent set-
ting of the laser power and PMT. It is expected that
different settings of the laser power and PMT generated
different signal intensities. Whether the same setting of
the laser power and PMT can generate consistent intensity
outcome over time has not been demonstrated. Using a
confocal laser scanner to minimize photo-bleaching
effects, we scanned microarrays slides at day 0, 10, 20 and
30, respectively. After regular antibody microarray experi-
ments, the microarray slides were stored in a laboratory
freezer at -20°C. Fluorescent intensities of microarray
spots at these time points were then quantified and com-
pared. Our results indicate no significant changes in
intensities of both Cy3 and Cy5 signals over the examined
period.
Results and discussion
Clontech™ antibody microarrays were used in this study,
which had 1024 microarray spots on each slide. Among
them, 6 spots were printed with fluorescence-labeled
albumin and served as positive controls, whereas 4 spots
were printed with non-labeled albumin and served as neg-
ative controls. For all microarray slides, the negative con-
trol spots had similar intensities as those of background
signals. These 10 control spots were not included in the
final microarray spot analyses. The remaining 1014 spots
on each microarray slide were followed up throughout the
entire length of the study. In order to keep the same exper-
imental condition, the following steps were taken: when a
storage vial containing the microarray slide was taken out
of the freezer, it was kept at room temperature for 30 min-
utes; and to keep the scan condition consistent, the same
strength of the laser power (100%) and PMT (65%) were
used for all scans of the microarray slides. No spot on the
microarray slides was saturated using these settings of the
laser power and PMT, so that unchanged intensities of
microarray spots due to saturation could be excluded in
the present study.
For each microarray spot, the signal intensity was meas-
ured 4 times, at day 0 (I0), day 10 (I10), day 20 (I20), and
day 30 (I30), respectively. Because I0 of each microarray
spot had a different value, we set I0 as the reference, and
calculated the ratio of I10/I0, I20/I0, and I30/I0, respectively,
for each of the 1014 spots on the microarray slide. If the
fluorescent signals on a microarray slide decrease over
time, the ratio value of I10/I0, I20/I0, and I30/I0 should
become smaller and smaller. Fourteen slides were exam-
ined for Cy3 and for Cy5, respectively.
Figure 1 shows an example of Cy3 signals on a microarray
slide at day 0, 10, 20, and 30, respectively. There was no
apparent decrease of Cy3 signal intensities.
Quantitative analyses of all Cy3 spots (summarized in
Table 1) further suggest that there was no statistically sig-
nificant change in intensities of Cy3 signals over the
examined time frame (p > 0.05, ANOVA).
Figure 2 shows an example of Cy5 signals on a microarray
slide at day 0, 10, 20, and 30, respectively. Like the case of
Cy3, there was no apparent decrease of Cy5 signal inten-
sities. Quantitative analyses of all Cy5 spots (summarized
in Table 2) also suggest that there was no statistically sig-
nificant change in intensities of Cy5 signals over the
examined time frame (p > 0.05, ANOVA).
Microarray spot signal intensities can span a broad range
from 0 to 65536 (= 216). To examine whether microarray
spots with different intensities behave differently over
time, we divided the microarray spots into three groups
according to their intensities: 1) lower range when I0 was
lower than 20000, 2) middle range when I0 was between
20000 and 40000, and 3) higher range when I0 was higher
than 40000, and calculated spot intensities in each group
of the Cy3-labeled (N = 14 slides) and in each group of
the Cy5-labeled (N = 14 slides) at day 0, 10, 20, and 30,
respectively. Quantitative analyses did not show statisti-
cally significant changes in intensities over the examined
time frame regardless of their intensities. (p > 0.05,
ANOVA).Proteome Science 2006, 4:21 http://www.proteomesci.com/content/4/1/21
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These results suggest that Cy3 and Cy5 signals on anti-
body microarrays are stable when the microarray slides
are stored in an airtight slide vial at -20°C. These results
are crucial to guide contemporary proteomics research
involving microarrays. For instance, occasionally microar-
ray slides could not be scanned soon after the experiment
due to time restrains. If this is inevitable, microarray slides
could be stored and scanned at a later time. Oftentimes, it
is determined that signals of some proteins on microarray
slides were too strong (e.g. saturated) after data analysis
has been done. In such cases, a rescan of microarray slides
is usually desirable with a reduced setting of the laser
power and/or PMT, so that signal intensities of these pro-
teins become non-saturated and suitable for data analy-
ses.
The signal intensities of microarray spots did not show a
significant decrease after repeated scans, suggesting that
the employed settings of the laser power and PMT were
adequate for multiple scans. We used a confocal microar-
ray scanner in our study, which, due to the confocal
nature of the laser beam, kept the bleaching effect of the
laser light minimal. However, whether a non-confocal
microarray scanner could achieve similar results as a con-
focal scanner remains to be determined. Also, we tested
only Cy3 and Cy5 dyes in the present study. It is possible
Table 1: Summary of ratio comparisons of Cy3 spots.
Slide Number
1 1.037 ± 0.004 1.086 ± 0.005 1.157 ± 0.006
2 1.008 ± 0.017 1.047 ± 0.004 1.087 ± 0.004
3 0.986 ± 0.003 1.025 ± 0.003 1.006 ± 0.002
4 1.021 ± 0.002 1.093 ± 0.002 0.988 ± 0.002
5 0.973 ± 0.007 1.006 ± 0.008 1.071 ± 0.009
6 1.044 ± 0.006 1.121 ± 0.007 1.104 ± 0.007
7 0.991 ± 0.008 0.990 ± 0.003 0.990 ± 0.003
8 0.982 ± 0.003 0.929 ± 0.003 0.948 ± 0.003
9 1.039 ± 0.004 1.051 ± 0.004 1.060 ± 0.004
10 1.055 ± 0.004 1.064 ± 0.006 1.001 ± 0.004
11 1.084 ± 0.009 1.142 ± 0.004 1.075 ± 0.004
12 1.066 ± 0.003 1.117 ± 0.012 1.026 ± 0.003
13 1.135 ± 0.007 1.138 ± 0.006 1.083 ± 0.021
14 0.985 ± 0.004 1.101 ± 0.003 1.114 ± 0.014
Average 1.029 ± 0.013 1.065 ± 0.018 1.051 ± 0.017
Each of the 1014 microarray spot was examined at day 0, 10, 20, and 30, respectively, and its intensities (I0, I10, I20, and I30) were measured. Then, 
the ratios of I10/I0, I20/I0, and I30/I0 for each microarray spot were generated. The average ratios of all 1014 spots on each individual slide at day 10 
(I10/I0), day 20 (I20/I0), and day 30 (I30/I0) as well as the averaged value of all slides at day 10, 20 and 30 are shown (mean ± SEM).
I/ I 10 0 I/ I 20 0 I/ I 30 0
Examples of Cy3 signals on a microarray slide scanned atday 0, 10, 20, and 30, respectively Figure 1
Examples of Cy3 signals on a microarray slide scanned atday 0, 10, 20, and 30, respectively. At day 0, the spot intensities on this 
slide range from 261 to 46409, with an average background intensity of 366 versus an average intensity of 488 for the 4 nega-
tive control spots. The scale bar on the right indicates color-coded signal intensities.Proteome Science 2006, 4:21 http://www.proteomesci.com/content/4/1/21
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that other fluorescent dyes may show similar results as
those of Cy3 and Cy5.
In theory, the fluorescent signal on microarray slides
should either remain the same or decrease in intensity but
is not expected to increase over time. However, we had a
few slides that displayed higher intensities at a later scan-
ning time point when compared to the intensities
acquired immediately after the drying procedure. Two
possibilities may be accountable for this phenomenon.
Such event could be attributed to the instability of the
laser power and/or PMT of the microarray scanner.
Another potential source of error may be due to incom-
plete drying of a microarray slide after the final centrifuga-
tion. Any remaining fluid in the slide holder may
evaporate and keep the microarray slide humid. The mois-
ture on microarray spots is reduced over time, which leads
to a stronger fluorescent signal.
In the present study we employed antibody microarray
slides from Clontech Laboratories Inc. (Mountain View,
California) for the following reasons: The Clontech™ anti-
body microarrays detect a wide variety of cytosolic, mem-
brane-bound, and nuclear proteins. Over 500 proteins
can be examined in a single experiment. As part of the
antibody microarray development, all antibodies have
been extensively tested to verify their specificity. Each is
raised against a known protein. Antibodies that display a
Table 2: Summary of ratio comparisons of Cy5 spots.
Slide Number
1 1.115 ± 0.013 1.102 ± 0.013 1.054 ± 0.013
2 1.139 ± 0.005 1.162 ± 0.007 1.141 ± 0.006
3 1.103 ± 0.006 1.185 ± 0.006 0.999 ± 0.072
4 1.150 ± 0.022 1.153 ± 0.020 1.053 ± 0.012
5 1.054 ± 0.007 1.133 ± 0.008 1.180 ± 0.009
6 1.170 ± 0.007 1.220 ± 0.008 1.191 ± 0.008
7 1.120 ± 0.006 1.093 ± 0.006 1.070 ± 0.012
8 0.999 ± 0.011 0.970 ± 0.003 1.010 ± 0.082
9 1.030 ± 0.004 0.978 ± 0.004 0.943 ± 0.004
10 1.055 ± 0.006 1.005 ± 0.007 1.054 ± 0.009
11 0.959 ± 0.005 0.957 ± 0.037 0.868 ± 0.003
12 0.902 ± 0.002 0.844 ± 0.002 0.814 ± 0.003
13 1.080 ± 0.006 0.996 ± 0.006 1.025 ± 0.007
14 0.932 ± 0.002 0.797 ± 0.003 0.828 ± 0.003
Average 1.058 ± 0.024 1.042 ± 0.037 1.016 ± 0.034
Each of the 1014 microarray spot was examined at day 0, 10, 20, and 30, respectively, and its intensities (I0, I10, I20, and I30) were measured. Then, 
the ratios of I10/I0, I20/I0, and I30/I0 for each microarray spot were generated. The average ratios of all 1014 spots on each individual slide at day 10 
(I10/I0), day 20 (I20/I0), and day 30 (I30/I0) as well as the averaged value of all slides at day 10, 20 and 30 are shown (mean ± SEM).
I/ I 10 0 I/ I 20 0 I/ I 30 0
Examples of Cy5 signals on a microarray slide scanned at day 0, 10, 20, and 30, respectively Figure 2
Examples of Cy5 signals on a microarray slide scanned at day 0, 10, 20, and 30, respectively. At day 0, the spot intensities on 
this slide range from 592 to 58229, with an average background intensity of 2504 versus an average intensity of 2512 for the 4 
negative control spots. The scale bar on the right indicates color-coded signal intensities.Proteome Science 2006, 4:21 http://www.proteomesci.com/content/4/1/21
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poor specific signal or a high level of cross-reactivity were
excluded from the antibody microarrays. In addition, all
antibodies were checked for the linearity of signal that can
be obtained, a necessary step to ensure accurate quantifi-
cation. Antibodies that show non-linear binding kinetics
were also excluded from the antibody microarrays. Each
antibody is double printed side-by-side on the microarray
slide to provide an additional internal control. The anti-
body microarrays are produced on standard 75 × 25 × 1
mm glass slides, an open platform that is compatible with
commercially available scanners commonly used for DNA
microarrays. Thus, the Clontech™ antibody microarrays
represent the most comprehensive antibody microarrays
to this date. Since the coupling of cyanine dyes (N-
hydroxysuccinimide-esters) to proteins is universal
through amines, our results should be applicable to other
types of antibody or protein microarrays as well.
A recent study showed that ozone levels in the laboratory
atmosphere could adversely affect intensities of fluores-
cent dyes such as Cy5 and Alexa 647 on DNA microarrays
[29]. The fact that fluorescent intensities did not show sig-
nificant decrease at day 10, 20, and 30 when compared to
those at day 0 suggests that the ozone level in our labora-
tory is not a critical component in our antibody microar-
ray experiments.
Based on our experience we summarize the key issues to
maintain the stability of fluorescent signals on microarray
slides as follows: 1) to dry the microarray slides thor-
oughly, 2) to keep them under a dry condition, 3) to store
them in a freezer (e.g. -20°C), and 4) to minimize light
exposure.
Conclusion
Microarray spot signals are more stable than previously
thought if microarray slides are stored at -20°C in an air-
tight slide vial. Microarray slides can be preserved and res-
canned multiple times using a confocal laser scanner over
a period of days or weeks.
Methods
Proteins extracted from visual cortex of young and adult
mice were used in this study. The use of animals and the
experimental procedures involving animals were
approved by the Animal Care and Use Committee of
Wake Forest University Health Sciences (Protocol number
A03-045). All animals were euthanized with an overdose
of pentobarbital (150 mg/kg body-weight). A conven-
tional two-color dye-swap protocol was used for antibody
microarray experiments [11,17,18,20,21]. In brief, pro-
teins were extracted using a protein extraction buffer
(Clontech, Mountain View, California), which contained
non-denaturing detergents. Tissue samples were homoge-
nized with alumina (0.5 g/100 mg tisue) and extraction
buffer (2 ml/100 mg tissue). The suspension was centri-
fuged at 10,000 × g for 30 minutes at 4°C. The superna-
tant was collected and its protein concentration was
measured using a Protein Assay Kit (Pierce, Rockford, Illi-
nois). The protein concentration was diluted to 1.1 mg/ml
by adding an appropriate volume of the extraction buffer.
The monoamine reactive dyes Cy3 and Cy5 (Amersham,
Piscataway, New Jersey) were dissolved in 110 µl extrac-
tion buffers, respectively. 50 µl dye solutions and 450 µl
protein solutions were mixed to generate 4 samples:
Adult-Cy3, Young-Cy3, Adult-Cy5, and Young-Cy5. After
90 minutes of incubation on ice, the labeling process was
stopped by adding 4 µl of 1 M ethanolamine. After pro-
tein labeling, unbound dyes were removed by gel filtra-
tion using disposable PD-10 desalting columns
(Amersham). Each column was equilibrated with 3 × 5 ml
desalting buffer (Clontech) before adding a protein sam-
ple, which was eluted by applying 2 ml desalting buffer.
The protein concentration in each sample was determined
using the Pierce Protein Assay Kit.
Two antibody microarray incubation solutions were made
with the following compositions: (1) 5 ml incubation
buffer (Clontech), 25 µg of the Adult-Cy3 protein sample,
and 25 µg of the Young-Cy5 protein sample, and (2) 5 ml
incubation buffer, 25 µg of the Adult-Cy5 protein sample,
and 25 µg of the Young-Cy3 protein sample. After 30 min-
utes incubation at room temperature with gentle rocking,
the antibody microarray slides (Clontech) were washed
with seven different wash buffers (Clontech) at 5 minutes
each, dried by centrifugation (1,000 × g) in a swing bucket
rotor at room temperature for 25 minutes, and scanned
using a confocal microarray scanner (ScanArray Gx) with
a pixel resolution of 5 µm. The excitation wavelength and
the emission filter wavelength for Cy3 and Cy5 were pre-
set by the scanner's manufacturer (Perkin-Elmer, Shelton,
Connecticut) at 543 nm/570 nm (excitation/emission)
and 633 nm/670 nm (excitation/emission), respectively.
After each scan, the microarray slide was put in a dry and
air-tight plastic vial, and stored in a -20°C freezer until the
next scan. Fluorescent signals of microarray spots were
quantified using ScanArray Express (Perkin-Elmer). The
mean intensity of the fluorescent signal within each
microarray spot as well as the mean background intensity
immediately surrounding the microarray spot was deter-
mined. The intensity of a microarray spot is defined as the
value of the spot mean intensity minus the background
mean intensity. Analysis of variance (ANOVA) was
applied to test statistic significance of signal intensities at
different time points, using signal intensities of the micro-
array spots as dependent variables and the microarray
spots (1014) and time points (4) as independent varia-
bles.Proteome Science 2006, 4:21 http://www.proteomesci.com/content/4/1/21
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